Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
about
Role of the gastroenterologist in managing obesityDiet and Pancreatic Cancer PreventionPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpEarly detection of pancreatic cancerCurrent status and progress of pancreatic cancer in ChinaEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaThe role of obesity in gastrointestinal cancer: evidence and opinionEnergy balance and metabolism after cancer treatmentPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersMetformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated MacrophagesExploring the metabolic syndrome: Nonalcoholic fatty pancreas diseaseObesity-Related Digestive Diseases and Their PathophysiologyAdjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinomaUpdate on the management of pancreatic cancer: surgery is not enoughGenome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populationsGenome-wide association study of survival in patients with pancreatic adenocarcinomaHigh risk factors of pancreatic carcinoma.Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy.Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanismPrevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres.Wellness: Pharmacy education's role and responsibility.Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.Screening for pancreatic cancer: why, how, and who?Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.Testicular cancer survivorship: research strategies and recommendations.Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).Obesity as an important risk factor for certain types of cancerNew strategies in pancreatic cancer: emerging epidemiologic and therapeutic conceptsCurrent and emerging therapies for the treatment of pancreatic cancer.Pancreatic adenocarcinomaEpidemiology of pancreatic cancer and the role of family historyObesity adversely affects survival in pancreatic cancer patients.Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studiesPancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Functional logistic regression approach to detecting gene by longitudinal environmental exposure interaction in a case-control study.Are risk factors associated with outcomes in pancreatic cancer?Micronuclei levels in peripheral blood lymphocytes as a potential biomarker for pancreatic cancer risk.Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studiesPancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida
P2860
Q22241486-47C656B3-BCA6-41CE-B7B6-6C88CFA84436Q26776524-878027ED-78C1-409E-B716-1FA0EA1D099BQ26780372-55D02EFA-FCCE-4B17-B441-F256EC7FBAF2Q26781558-B9B7D48E-E659-4BD7-890D-0C94B24B0D78Q26799739-22AFB3D9-09AC-4C52-92D8-50D8A412D2D9Q26801418-EB7DCD7C-1B3E-47FB-AD02-A23F9D9A7D51Q26825678-C76EF7F8-330D-4B8A-A457-9EEA2CC726A9Q27015118-DCE3E9D1-CFF9-4901-8D51-8711F48862A3Q27022231-7F661A18-24C7-4CF6-BF58-FFDE106D2D92Q27348974-74EBC526-0A04-40F0-A4AA-00F32B3421ACQ28069643-C0BA7F60-A291-4FDB-A73B-DA9341032609Q28073381-1A38DE91-F297-411E-9EAB-69BED911A4DDQ28074614-5F58E472-DF3C-4B8C-835E-9E1A4DA7BCBBQ28087060-6D186B9A-7082-4C57-8C5B-8E704583DD1CQ28943254-EAA755A6-1887-457D-AB44-69E4A41763E4Q28943489-B218E576-EB4D-42DE-AACF-4530CBB47BD4Q30249161-883E11C8-82F9-4ACA-A1C7-07F3235DD4EAQ30388746-EDB249A6-3F29-4044-9EF4-56FE1B3D3137Q33694161-1DA0B521-A787-42CB-8B3D-6880B3BE531BQ33747381-03916D4B-3936-45B9-B281-C9AE82EAEB78Q33887540-1F33B737-3DFB-46EB-9A82-E16D1FCD7502Q33894658-810F32BA-40C0-4B9D-9C09-7F923E2C8F33Q33959412-99CB4F51-8816-45B6-8220-AA12338203D4Q33996477-EF99CE11-B1E5-4040-B262-12169BB714C7Q34039684-26223D47-7657-46C7-A570-9791B9E4ACE3Q34059780-762709ED-24A4-4F8B-9080-146DB39ADE0FQ34082428-F3FD2F39-E398-4B6B-959C-73712F6D9612Q34101569-2B27E09D-B353-4C4A-B205-330ACADF623BQ34129346-3E49FF2B-15E8-4658-BEEE-D3D4F604B51BQ34140498-DC5498E5-6175-4D79-A28E-EF17F4B6F5EEQ34155002-93A15E08-7AC4-4387-A108-F22481798FB5Q34238737-719BBFE8-A140-4844-9D62-6386D4FB4404Q34242557-B645C084-05A3-452F-9BAC-DFC55DB88924Q34301038-7ECFB152-A0F1-4FE6-A03A-AA9A3C8B51E3Q34307550-8CB52F55-553E-4447-BD5A-3F78F9242568Q34388277-29D1606A-C119-4A4D-BB2E-DF629683E115Q34520438-5DA3DBB2-6B6A-430D-93AF-88CD6848CD9AQ34566049-C48F006E-B5C7-4BED-8C7C-32B2C436F6FBQ34625360-EB400FFE-2DDF-424F-9B8E-B461E645E2BEQ34627738-1FCCA6EA-58B6-47C8-B3D5-4F64F339F411
P2860
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@ast
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@en
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@nl
type
label
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@ast
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@en
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@nl
prefLabel
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@ast
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@en
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@nl
P2093
P2860
P356
P1476
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer
@en
P2093
Donghui Li
James L Abbruzzese
Jeffrey S Morris
Manal M Hassan
Melissa L Bondy
P2860
P304
P356
10.1001/JAMA.2009.886
P407
P577
2009-06-01T00:00:00Z